Skip to main content
. 2015 May 5;10(5):e0125512. doi: 10.1371/journal.pone.0125512

Fig 1. Adjusted risk of CKD Stages 1–2 (Panel A), CKD Stages 3–5 nonalbuminuric (Panel B) and CKD Stages 3–5 albuminuric (Panel C) (OR [95% CI]) according to deciles of triglyceride levels in subjects without (□) and with (●) statin treatment.

Fig 1

ORs are adjusted for age, male gender, smoking status, diabetes duration, HbA1c, BMI, HDL and LDL cholesterol, hypertension, and blockade of the renin-angiotensin system. Significant at * P<0.0001, † P at least <0.01, ‡ P at least <0.05.